These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 2566379)
1. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells. Meyers MB; Rittmann-Grauer L; O'Brien JP; Safa AR Cancer Res; 1989 Jun; 49(12):3209-14. PubMed ID: 2566379 [TBL] [Abstract][Full Text] [Related]
2. Reversal of Vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft. Rittmann-Grauer LS; Yong MA; Sanders V; Mackensen DG Cancer Res; 1992 Apr; 52(7):1810-6. PubMed ID: 1348013 [TBL] [Abstract][Full Text] [Related]
3. Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells. Hamada H; Okochi E; Watanabe M; Oh-hara T; Sugimoto Y; Kawabata H; Tsuruo T Cancer Res; 1988 Dec; 48(24 Pt 1):7082-7. PubMed ID: 2903793 [TBL] [Abstract][Full Text] [Related]
4. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein. Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Schinkel AH; Roelofs EM; Borst P Cancer Res; 1991 May; 51(10):2628-35. PubMed ID: 1673638 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells. Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532 [TBL] [Abstract][Full Text] [Related]
7. Protein phosphorylation in multidrug resistant Chinese hamster cells. Meyers MB Cancer Commun; 1989; 1(4):233-41. PubMed ID: 2576975 [TBL] [Abstract][Full Text] [Related]
8. Transfer of adriamycin resistance by fusion of Mr 170,000 P-glycoprotein to the plasma membrane of sensitive cells. Belli JA; Zhang Y; Fritz P Cancer Res; 1990 Apr; 50(7):2191-7. PubMed ID: 1969329 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of multidrug resistance in HL60 cells: detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein. Marquardt D; McCrone S; Center MS Cancer Res; 1990 Mar; 50(5):1426-30. PubMed ID: 1967979 [TBL] [Abstract][Full Text] [Related]
10. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells. Kavallaris M; Madafiglio J; Norris MD; Haber M Biochem Biophys Res Commun; 1993 Jan; 190(1):79-85. PubMed ID: 8093660 [TBL] [Abstract][Full Text] [Related]
11. Identification of a P-glycoprotein-related protein (mini-P-glycoprotein) which is overexpressed in multidrug resistant cells. Kawai K; Kusano I; Ido M; Sakurai M; Shiraishi T; Yatani R Biochem Biophys Res Commun; 1994 Jan; 198(2):804-10. PubMed ID: 7905266 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of multidrug resistance in HL60 cells: evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug. McGrath T; Center MS Cancer Res; 1988 Jul; 48(14):3959-63. PubMed ID: 2898287 [TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate. Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416 [TBL] [Abstract][Full Text] [Related]
14. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Yusa K; Tsuruo T Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930 [TBL] [Abstract][Full Text] [Related]
15. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines. Cass CE; Janowska-Wieczorek A; Lynch MA; Sheinin H; Hindenburg AA; Beck WT Cancer Res; 1989 Nov; 49(21):5798-804. PubMed ID: 2790792 [TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies. Politi PM; Arnold ST; Felsted RL; Sinha BK Mol Pharmacol; 1990 Jun; 37(6):790-6. PubMed ID: 1972771 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines. Chu TM; Kawinski E; Lin TH Hybridoma; 1993 Aug; 12(4):417-29. PubMed ID: 7503940 [TBL] [Abstract][Full Text] [Related]
18. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line. Hill AB; Beck WT; Trent JM Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436 [TBL] [Abstract][Full Text] [Related]
19. Vincristine-resistant human leukemia cell line: new monoclonal antibodies to a 65kDa membrane protein. Kakihara T; Yamada T; Fukuda T; Ohnishi Y; Kishi K; Shibata A Leuk Lymphoma; 1992 May; 7(1-2):157-64. PubMed ID: 1472928 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to glycoproteins of Vinca alkaloid-resistant human leukemic cells. Danks MK; Metzger DW; Ashmun RA; Beck WT Cancer Res; 1985 Jul; 45(7):3220-4. PubMed ID: 3891080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]